Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - A randomized, controlled, open-label, multicenter study

American Journal of Gastroenterology

Volumn 100, Issue 11, 2005, Pages 2503-2509

  Schröder, Oliver ^a   Mickisch, Oliver ^b   Seidler, Ursula ^c   De Weerth, Andreas ^d   Dignass, Axel U ^e   Herfarth, Hans ^f   Reinshagen, Max ^g   Schreiber, Stefan ^h   Junge, Ulrich ^a   Schrott, Marc ^a   Stein, Jürgen ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Hannover Medical School ^*

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g UNIVERSITY OF KIEL   (Germany)

^h Christian Albrechts University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FERRIC HYDROXIDE SUCROSE; FERRO SANOL; FERROUS SULFATE; HEMOGLOBIN; PREDNISOLONE; TRANSFERRIN; ANTIANEMIC AGENT; FERRIC ION; FERRIC OXIDE, SACCHARATED; FERRIC SULFATE; FERRITIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; ENTERITIS; EVALUATION; FEMALE; FERRITIN BLOOD LEVEL; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INJECTION SITE CELLULITIS; INSOMNIA; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALE; MULTICENTER STUDY; MUSCLE CRAMP; MYALGIA; NAUSEA; OPEN STUDY; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URTICARIA; VEIN THROMBOSIS; VOMITING; ADOLESCENT; AGED; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; FEMALE; FERRIC COMPOUNDS; FERRITINS; FOLLOW-UP STUDIES; HEMATINICS; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDIES; TRANSFERRIN; TREATMENT OUTCOME;

EID: 33644653558     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00250.x     Document Type: Article

References (31)

1. Beal RW Skyring AP McRae J, et al. The anemia of ulcerative colitis. Gastroenterology 1963 45 : 589 603.
2. Both H Torp-Pedersen K Kreiner S, et al. Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scand J Gastroenterol 1983 18 : 987 91.
3. Gasché C Reinisch W Lochs H, et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994 39 : 1930 34.
4. Schreiber S Howaldt S Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996 334 : 619 23.
5. Cronin CC Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 2001 96 : 2296 8.
6. Gasché C Lomer MC Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut 2004 53 : 1190 97.
7. Liguori L. Iron protein succinylate in the treatment of iron deficiency: Controlled, double-blind, multicenter clinical trial on over 1,000 patients. Int J Clin Pharmacol Ther Toxicol 1993 31 : 103 23.
8. Coplin M Schuette S Leichtmann G, et al. Tolerability of iron: A comparison of bis-glycino iron II and ferrous sulfate. Clin Ther 1991 13 : 606 12.
9. Troost FJ Saris WH Haenen GR, et al. New method to study oxidative damage and antioxidants in the human small bowel: Effects of iron application. Am J Physiol Gastrointest Liver Physiol 2003 285 : G354 9.
10. Erichsen K Hausken T Ulvik RJ, et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003 38 : 543 8.
11. Oldenburg B van Berge Henegouwen GP Rennick D, et al. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000 30 : 505 10.
12. Carrier J Aghdassi E Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001 15 : 1989 99.
13. Uritski R Barshack I Bilkis I, et al. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr 2004 134 : 2251 5.
14. Seril DN Liao J Ho KL, et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002 47 : 1266 78.
15. Gasché C Dejaco C Reinisch W, et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999 60 : 262 7.
16. Gasché C Dejaco C Waldhoer T, et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997 126 : 782 7.
17. Schröder O Schrott M Blumenstein I, et al. A pilot study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal blood loss. Z Gastroenterol 2004 42 : 663 7.
18. Danielson BG Salmonson T Derendorf H, et al. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittelforschung 1996 46 : 615 21.
19. Yee J Besarab A. Iron sucrose: The oldest iron therapy becomes new. Am J Kidney Dis 2002 40 : 1111 21.
20. Brazier J Harper R Jones N. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. BMJ 1992 305 : 160 64.
21. ICSH. Recommendations for the measurement of serum iron in human blood. Br J Haematol 1978 38 : 291 4.
22. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 1989 298 : 82 6.
23. Best WR Becktel JM Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
24. Goddard AF McIntyre AS Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut 2000 46 ( suppl 3-4 IV1 5.
25. Sayer JM Long RG. A perspective on iron deficiency anaemia. Gut 1993 34 : 1297 9.
26. Erichsen K Ulvik RJ Nysaeter G, et al. Oral versus intravenous iron therapy in patients with inflammatory bowel disease. Gut 2004 53 ( suppl VI A220 ( abstract).
27. Ablin J Shalev O Okon E, et al. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis 1999 5 : 253 61.
28. Millar AD Rampton DS Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 2000 14 : 1163 8.
29. Seril DN Liao J Ho KL, et al. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 2002 23 : 993 1001.
30. Bayoumeu F Subiran-Buisset C Baka NE, et al. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol 2002 186 : 518 22.
31. Stewart WB Yuile CL Claiborne HA, et al. Radioiron absorption in anemic dogs: Fluctuations in the mucosal block and evidence for a gradient of absorption in the gastrointestinal tract. J Exp Med 1950 92 : 375 82.